ONTO INNOVATION INC.
Business
ONTO INNOVATION INC. is a global provider of metrology, inspection and process control systems for the semiconductor industry. It offers automated optical metrology, macro-defect inspection, materials characterization, advanced packaging lithography, opaque film metrology and process control and yield management software. The business is organized around product families and solutions including automated metrology (Atlas), integrated metrology (IMPULSE), macro-defect inspection (Firefly/Dragonfly), lithography (JetStep) and software suites for APC and yield management. Products are sold to semiconductor wafer manufacturers, IC fabricators and advanced packaging firms through direct sales, field service and selected channel partners worldwide.
Summary from filing dated 2025-02-25
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 1,005 | 987 | 816 | 1,005 | 789 | |
| Cost of revenue | 505 | 472 | 396 | 466 | 360 | |
| Gross profit | 500 | 515 | 420 | 539 | 429 | |
| Research and development | 132 | 114 | 104 | 112 | 96 | |
| Sales and marketing | 70 | 76 | 62 | 66 | 57 | |
| General and administrative | 107 | 80 | 80 | 70 | 68 | |
| Amortization | 39 | 49 | 55 | 55 | 51 | |
| Restructuring cost in operating expenses | −18 | −9 | −4 | — | — | |
| Total operating expenses | 367 | 328 | 304 | 303 | 273 | |
| Operating income (loss) | 133 | 187 | 116 | 237 | −156 | |
| Interest income, net | 35 | 33 | 20 | 5 | 1 | |
| Other income (expense), net | −5 | −145,000 | −4 | −141,000 | −2 | |
| Income (loss) before provision (benefit) for income taxes | 163 | 220 | 133 | 242 | −156 | |
| Provision (benefit) for income taxes | 26 | 19 | 11 | 18 | 13 | |
| Net income | 137 | 202 | 121 | 223 | 142 | |
| Basic (per share) | 2.78 | 4.09 | 2.47 | 4.52 | 2.89 | |
| Diluted (per share) | 2.78 | 4.06 | 2.46 | 4.49 | 2.86 | |
| Basic (shares) | 49 | 49 | 49 | 49 | 49 | |
| Diluted (shares) | 49 | 50 | 49 | 50 | 50 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 346 | 213 | 234 | 176 | 170 | |
| Marketable securities | 294 | 639 | 464 | 372 | 342 | |
| Accounts receivable, less allowance of $2,585 at December 28, 2024 and $2,659 at December 30, 2023 | 269 | 308 | 227 | 241 | 177 | |
| Inventories | 298 | 287 | 328 | 324 | 243 | |
| Prepaid expenses and other current assets | 61 | 30 | 31 | 21 | 16 | |
| Total current assets | 1,268 | 1,478 | 1,283 | 1,135 | 948 | |
| Property, plant and equipment, net | 127 | 124 | 104 | 92 | 82 | |
| Goodwill | 644 | 330 | 316 | 316 | 316 | |
| Identifiable intangible assets, net | 298 | 127 | 167 | 222 | 277 | |
| Deferred income taxes | 4 | 43 | 19 | 5 | 5 | |
| Other assets | 27 | 15 | 21 | 25 | 22 | |
| Total assets | 2,368 | 2,117 | 1,910 | 1,795 | 1,650 | |
| Accounts payable | 108 | 56 | 50 | 55 | 53 | |
| Accrued liabilities | 49 | 50 | 42 | 49 | 43 | |
| Deferred revenue | 32 | 34 | 25 | 30 | 30 | |
| Other current liabilities | 31 | 30 | 31 | 27 | 28 | |
| Total current liabilities | 219 | 170 | 148 | 161 | 155 | |
| Deferred and other tax liabilities | 20 | 4,000 | 0 | 7 | 40 | |
| Other non-current liabilities | 28 | 21 | 25 | 31 | 29 | |
| Total liabilities | 267 | 191 | 173 | 198 | 224 | |
| Commitments and contingencies (Note 9) | — | — | — | — | — | |
| Preferred stock, $0.001 par value, 3,000 shares authorized, no shares issued and outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.001 par value, 97,000 shares authorized, 49,238 and 49,086 issued and outstanding at December 28, 2024 and December 30, 2023, respectively. | 50,000 | 49,000 | 49,000 | 49,000 | 49,000 | |
| Additional paid-in capital | 1,367 | 1,275 | 1,262 | 1,244 | 1,256 | |
| Accumulated other comprehensive income | −10 | −14 | −8 | −10 | 1 | |
| Accumulated earnings | 744 | 665 | 482 | 363 | 169 | |
| Total stockholders equity | 2,101 | 1,926 | 1,737 | 1,596 | 1,426 | |
| Total liabilities and stockholders equity | 2,368 | 2,117 | 1,910 | 1,795 | 1,650 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income | 137 | 202 | 121 | 223 | 142 | |
| Depreciation | 21 | 13 | 12 | 9 | 14 | |
| Accretion (Amortization) of Discounts and Premiums, Investments | 5 | 7 | 5 | — | — | |
| Share-based compensation | 28 | 29 | 26 | 24 | 20 | |
| Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Writeoff | 0 | 4 | 0 | 6 | 0 | |
| Provision for inventory valuation | 26 | 19 | 10 | 9 | 8 | |
| Deferred income taxes | 13 | −26 | −22 | −34 | −13 | |
| Other, net | 9 | 722,000 | 3 | 563,000 | 2 | |
| Accounts receivable | 54 | −84 | 12 | −65 | −28 | |
| Income taxes | −20 | 3 | 2 | 5 | 1 | |
| Inventories | −3 | 20 | −16 | −94 | −57 | |
| Prepaid expenses and other assets | −2 | 9 | −9 | −5 | −768,000 | |
| Accounts payable | 51 | 6 | −5 | 1 | 12 | |
| Accrued and other liabilities | −19 | 8 | −11 | 11 | 22 | |
| Net cash and cash equivalents provided by operating activities | 328 | 246 | 172 | 137 | 175 | |
| Purchases of marketable securities | −476 | −709 | −480 | −371 | −361 | |
| Proceeds from maturities and sales of marketable securities | 827 | 541 | 397 | 339 | 255 | |
| Purchases of property, plant and equipment | −29 | −32 | −23 | −18 | −12 | |
| PaymentsToAquireNonMarketableSecurities | 8 | 0 | 0 | — | — | |
| Proceeds from sale of property, plant and equipment | 0 | 0 | 3 | 0 | 0 | |
| Purchase of business, net of cash acquired | −436 | −27 | 0 | −5 | −24 | |
| Net cash and cash equivalents provided by (used in) investing activities | −122 | −227 | −103 | −56 | −142 | |
| Purchases of common stock | −75 | −25 | −3 | −65 | 0 | |
| Tax payments related to shares withheld for share-based compensation plans | −14 | −19 | −11 | −9 | −7 | |
| Payment of contingent consideration for acquired business | 0 | −737,000 | −801,000 | −2 | 0 | |
| Issuance of shares through share-based compensation plans | 13 | 9 | 5 | 8 | 10 | |
| Net cash and cash equivalents provided by (used in) financing activities | −75 | −36 | −9 | −68 | 3 | |
| Effect of exchange rate changes on cash and cash equivalents | 2 | −4 | −1 | −6 | −3 | |
| Net increase in cash and cash equivalents | 133 | −21 | 58 | 6 | 33 | |
| Income taxes paid (received), net | 36 | 36 | 34 | 59 | 24 |